ENDRA Life Sciences (NDRA) Asset Writedowns and Impairment (2018 - 2019)
ENDRA Life Sciences (NDRA) posted quarterly Asset Writedowns and Impairment of $249256.0 for Q4 2019, down 13.31% sequentially from $287541.0 in Q3 2018.
ENDRA Life Sciences (NDRA) Asset Writedowns and Impairment (2018 - 2019) Analysis & Trends
ENDRA Life Sciences has disclosed Asset Writedowns and Impairment across 2 years of filings, most recently posting $249256.0 for Q4 2019.
- In Q4 2019, Asset Writedowns and Impairment changed N/A year-over-year to $249256.0; the TTM figure through Dec 2019 stood at $536797.0 (up 86.69% YoY), while the FY2019 annual figure was $249256.0, down 13.31% from the prior year.
- Asset Writedowns and Impairment declined to $249256.0 in Q4 2019, from $287541.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for NDRA reached as high as $287541.0 in Q3 2018 and fell as low as $249256.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 249,256.00 |
| Dec 31, 2019 | 249,256.00 |
| Sep 30, 2018 | 287,541.00 |
| Sep 30, 2018 | 287,541.00 |